Cyanide antidote launched

Cyanokit is an injectable preparation of hydroxocobalamin (vitamin B12) indicated for the treatment of known or suspected cyanide poisoning.

Hydroxocobalamin has a favourable safety profile in patients who have not been poisoned, making Cyanokit a useful option when cyanide exposure is unproven.
Hydroxocobalamin has a favourable safety profile in patients who have not been poisoned, making Cyanokit a useful option when cyanide exposure is unproven.

Cyanokit must be used alongside adequate supportive measures, including maintenance of airway patency, oxygen therapy, hydration, cardiovascular support and management of seizures.

Cyanide has a large number of industrial applications; poisoning with this substance typically occurs as a result of smoke inhalation or occupational exposure.

Hydroxocobalamin reacts with cyanide to form cyanocobalamin, which is eliminated in the urine.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Drug shortages - live tracker

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

Live updates: Coronavirus (COVID-19) in the UK

Live updates: Coronavirus (COVID-19) in the UK

Use our timeline to follow the latest coronavirus developments...

Consider bisphosphonates to combat osteoporosis risk in asthma patients taking steroids, say researchers
Medicines shortages increase as prescribing costs rise £158 million

Medicines shortages increase as prescribing costs rise £158 million

Increasing medicines shortages have added more than...